Mesothelioma stratified therapy (MiST): a phase IIA umbrella trial for accelerating the development of precision medicines
Authors
Fennell, DHudka, M
Darlison, L
Lord, K
Bzura, A
Dzialo, J
Pritchard, C
Harber, J
Takata, T
Popat, S
Krebs, Matthew G
Nolan, L
Greystoke, A
Richards, C
Wells-Jordan, P
Branson, A
Gaba, A
Bhundia, V
Scotland, M
Mohamed, S
Dawson, A
Poille, C
Cowley, C
Walter, H
King, A
Thomas, A
Affiliation
Leicester Cancer Research Centre, University of Leicester & University Hospitals of Leicester, Leicester/GBIssue Date
2019
Metadata
Show full item recordCitation
Fennell D, Hudka M, Darlison L, Lord K, Bzura A, Dzialo J, et al. P2.06-02 Mesothelioma Stratified Therapy (MiST): A Phase IIA Umbrella Trial for Accelerating the Development of Precision Medicines. Journal of Thoracic Oncology. 2019;14(10):S755-S6.Journal
Journal of Thoracic OncologyDOI
10.1016/j.jtho.2019.08.1620Additional Links
https://dx.doi.org/10.1016/j.jtho.2019.08.1620Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jtho.2019.08.1620